2011 DEA History Policy 
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.
Cannabis Law Report
FEBRUARY 28, 2022
Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. 640, 640 (2011). This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. Because they were criminalized for decades, the U.S. See Rachel Quibell et al., Ketamine , 41 J.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 1, 2019
8 In January of this year, Attorney General Jeff Sessions rescinded an Obama-era policy which had de-prioritized federal prosecution of those involved in the cannabis industry in states which had legalized medical or recreational cannabis. 7 In 2011, Laura Duffy, then U.S. any other Federal criminal statute.” 5 [link] ; [link].
Cannabis Law Report
MAY 24, 2022
Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. To consider the full impact of this Supreme Court decision it is necessary to delve into the history of the Controlled Substance Act.
SpeedWeed
MAY 5, 2021
Chemdog is a legendary strain in the history of cannabis. This rest is weed history. . Double unfortunately, those were lost when Chemdog was busted by the DEA and IRS in 2011. . Answer: About as sick to my stomach as Greg felt when he left those seeds in a Vegas hotel room. Who and what is Chemdog? View original article.
Cannabis Law Report
APRIL 8, 2022
To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Lyle Craker, Ph.D., million in the form of a bequest.
Cannabis Law Report
SEPTEMBER 23, 2019
During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.
Expert insights. Personalized for you.
104 
Let's personalize your content